Capula Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-243
Closed -$20.7K 776
2026
Q1
$20.7K Sell
243
-4,133
-94% -$368K ﹤0.01% 1041
2025
Q4
$346K Buy
4,376
+2,667
+156% +$209K ﹤0.01% 458
2025
Q3
$137K Buy
1,709
+742
+77% +$63.3K ﹤0.01% 682
2025
Q2
$87.9K Sell
967
-57
-6% -$5.2K ﹤0.01% 523
2025
Q1
$95.9K Sell
1,024
-3,092
-75% -$277K ﹤0.01% 624
2024
Q4
$374K Buy
+4,116
New +$393K ﹤0.01% 200
2021
Q4
Sell
-61,196
Closed -$4.6M 292
2021
Q3
$4.6M Buy
61,196
+52,935
+641% +$4.2M 0.06% 246
2021
Q2
$668K Buy
+8,261
New +$675K 0.01% 410
2020
Q2
Sell
-10,200
Closed -$725K 326
2020
Q1
$677K Buy
10,200
+5,490
+117% +$387K 0.02% 328
2019
Q4
$324K Buy
+4,710
New +$321K 0.01% 331

Other funds holding CL

Capula Management's CL Position: Q2 2026 in Review

Capula Management sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 243 shares — an estimated $20.7K sold.

Capula Management first reported a position in CL in Q4 2019 and held it in 10 quarters. The position peaked at $4.6M in Q3 2021. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Capula Management reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 243 Colgate-Palmolive shares in Q2 2026, an estimated $20.7K.
  • Capula Management first reported a position in Colgate-Palmolive in Q4 2019 and held it in 10 quarters.
  • Capula Management's Colgate-Palmolive position peaked at $4.6M in Q3 2021.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.